Trial Details

COMPLETED
Basic Information
Clinical ID c815
Identifier NCT00430898
Trial Title Basiliximab in Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Basiliximab
Participant Information
Sponsor Cerimon Pharmaceuticals
City Anaheim
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-01-07
Primary Completion Date 2025-09-08
Completion Date 2025-09-08